NCT02798341View on ClinicalTrials.gov

The Breast Program - Translational Cancer Resource

Active, not recruitingOBSERVATIONAL
Enrollment

4,000

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2030

Conditions
Breast Cancer
Interventions
OTHER

Biospecimen Collection

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT02798341 - The Breast Program - Translational Cancer Resource | Biotech Hunter | Biotech Hunter